SEC EDGAR · Company announcement
PG: Leadership change · Company disclosure
Filed 8-K for an event or period dated 2026-07-29. Leadership change; Company disclosure.
Follow PG- Became public
- Jul 29, 2026, 7:05 AM EDT
- Event / period date
- Jul 29, 2026
- Collected
- Nov 9, 2026, 2:46 PM EST
Why this is connected
This filing identifies PROCTER & GAMBLE Co as the issuer of the security. The company's SEC identifier connects it to PG.
News Release by The Procter & Gamble Company dated July ↗Source evidence
Read the source excerpt or record
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On July 29, 2026, The Procter & Gamble Company (the "Company") announced that Jon R. Moeller, Executive Chairman of the Board, will retire from his position as Executive Chairman and as a member of the Board of Directors (“the Board”), effective July 31, 2026. Mr. Moeller will remain with the Company through August 14, 2026, when he will retire from the Company. The Company also announced that Shailesh G. Jejurikar, currently President and Chief Executive Officer and a member of the Board, has been appointed Chairman of the Board, in addition to his current responsibilities, effective August 1, 2026, to serve at the pleasure of the Board. In addition, the non-employee Directors of the Board reappointed Joseph Jimenez as the Board’s independent Lead Director. The Company is filing the information under this item pursuant to Item 5.02, "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers." ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on July 29, 2026, announcing Mr. Moeller’s retirement and Mr. Jejurikar’s appointment. A copy of this news release is furnished as Exhibit 99.1 The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, "Regulation FD Disclosure." ITEM 9.01 - FINANCIAL STATEMENTS AND EXHIBITS Exhibit No. Description 99.1 Dividend News Release by The Procter & Gamble Company dated July 29, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of
Price change after we could observe it
-0.37% PG
Adjusted closing prices from Nov 10, 2026 to Nov 12, 2026. SPY changed 0.96% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Congressional trading in PG
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
Bought The Procter & Gamble Company PG
$1K–$15K · Traded Oct 23, 2026 · disclosed Nov 5, 2026
- Nov 5, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
Bought The Procter & Gamble Company PG
$1K–$15K · Traded Oct 23, 2026 · disclosed Nov 5, 2026
- Oct 27, 2026$1K–$15K
Rep. Pete Sessions (R-TX-17)
Sold The Procter & Gamble Company PG
$1K–$15K · Traded Oct 8, 2026 · disclosed Oct 27, 2026
Traded 14 days before earnings - Oct 15, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
Sold The Procter & Gamble Company PG
$1K–$15K · Traded Oct 12, 2026 · disclosed Oct 15, 2026
Traded 10 days before earnings - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought The Procter & Gamble Company PG
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought The Procter & Gamble Company PG
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold The Procter & Gamble Company PG
$1K–$15K · Traded Sep 2, 2026 · disclosed Oct 7, 2026 · Dependent
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold The Procter & Gamble Company PG
$1K–$15K · Traded Sep 2, 2026 · disclosed Oct 7, 2026 · Spouse
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.